Cardiovascular Safety of Celecoxib NEJM

In patients at high risk of both cardiovascular and gastrointestinal events who require concomitant aspirin and NSAID, celecoxib plus proton-

Treatment with a 400-mg dose of celecoxib twice daily for three years reduced the incidence of recurrent adenomas of any type by 45 percent and of high-risk

celecoxib Celecoxib Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug

celecoxib 200 mg Celecoxib at daily doses of 200 mg